Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Pure Global Cannabis Inc PRCNF

Pure Global Cannabis Inc is a growth-oriented life science cannabis company led by experienced pharma-industry, horticultural and supply chain experts.


GREY:PRCNF - Post by User

Comment by Jonassson May 12, 2019 11:27pm
87 Views
Post# 29740130

RE:going to zero

RE:going to zeroSo you're saying all MJ companies will go to zero because of oversupply or just PURE?
MobileData wrote:

Many Canadian licensed producers might never achieve profitability and eventually lose ground to their American counterparts because of oversupply and onerous marketing restrictions — the combination of which will lead to commoditization, according to some investors in the cannabis space.

“There are 150 companies, millions of square feet of greenhouse space presumably coming online in the next three to five years, and just 35 million people. This is going to turn into the microbrewery business where no one makes any money,” said Igor Gimelshtein, the former chief financial officer of MedReleaf Corp., one of the first licensed producers in Canada that was acquired by Aurora Cannabis Inc. just under a year ago.

Gimelshtein, who is currently a partner at Zola Global, a family office that focuses on investing primarily in the American cannabis space, said he was eager to sell Medreleaf last year because he believes an oversupply situation will be forthcoming in the next few years.




<< Previous
Bullboard Posts
Next >>